Newark, New Castle, USA, May 09, 2023 (GLOBE NEWSWIRE) -- According to a recent report published by Growth Plus Reports, the non-hormonal birth control market was valued at US$ 27.68 billion in 2022 and will reach US$ 52.19 billion in 2031. The market is expected to register a CAGR of 7.3% from 2023 to 2031. Growth Plus Reports provide a comprehensive analysis of the global non-hormonal birth control market, with data and forecasts spanning the years 2023 to 2031.
Key Takeaways:
The increasing need for contraceptives to prevent unwanted pregnancies will drive market revenue growth.
Increasing awareness of birth control supports market revenue growth.
North America accounts for the largest revenue share of the market.
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Market Drivers The growing demand for birth control methods that are natural or holistic and do not rely on synthetic chemicals will drive the market's revenue growth. Furthermore, non-hormonal birth control technology advancements, the availability of more practical and effective options, and the benefits of using non-hormonal birth control techniques are expected to fuel the market's revenue growth.
Market Segmentation Growth Plus Reports has analyzed the global non-hormonal birth control market from three perspectives: Type, Gender, and Region.
Based on the type, the non-hormonal birth control market is segmented into contraceptive devices and sterilization.
Based on gender, the non-hormonal birth control market is segmented into male and female.
Type Segmentation Based on the type, the non-hormonal birth control market is segmented into contraceptive devices and sterilization. Condoms, diaphragms, cervical caps, sponges, vaginal rings, copper intrauterine devices (IUD), and other devices are among the contraceptive devices available. Since they are more user-friendly and have higher effectiveness rates, the contraceptive devices segment dominates the market with the highest revenue.
Regional Growth Dynamics Based on the region, the global non-hormonal birth control market is segmented into North America, Europe, Latin America, and the Middle East & Africa. North America dominates the non-hormonal birth control market with the largest revenue share due to the high levels of alternative birth control education and awareness, strict birth control product regulations, the availability of safe and effective non-hormonal options, increased research and development efforts, and the introduction of new products and technologies.
Competitive Landscape
The top companies in the non-hormonal birth control market are:
CooperSurgical, Inc.
Reckitt Benckiser Group Plc
Mayer Laboratories, Inc.
Bayer AG
Abbvie (Allergan)
LifeStyles Healthcare Pte Ltd
Caution Wear Corp.
Church & Dwight Co., Inc.
Cupid Limited
Karex Berhad
CPR GmbH
ONE Condoms
Sagami Rubber Industries Co., Ltd.
Okamoto Industries, Inc.
Because of the existence of numerous multinational corporations, the market for non-hormonal birth control is very competitive. Key corporations make alliances, mergers, and acquisitions to increase their market revenue share.
Recent Developments:
An NIH-funded group of researchers at Weill Cornell Medicine in February 2023 created a substance called TDI-11861 that binds to and inhibits soluble adenylyl cyclase, a crucial hormone that signals sperm to travel through the female reproductive tract and fertilizes the egg. On March 20, 2023, the researchers presented their findings at the American Chemical Society (ACS) spring meeting.
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2021
Base Year – 2022
Forecast Years – 2023 to 2031
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2022)
Regulatory Landscape
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL NON-HORMONAL BIRTH CONTROL MARKET - ANALYSIS & FORECAST, BY TYPE
Contraceptive Devices
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Others
Sterilization
Vasectomy
Tubectomy
GLOBAL NON-HORMONAL BIRTH CONTROL MARKET - ANALYSIS & FORECAST, BY GENDER
Minimally Invasive Spine Technologies Market by Type (Percutaneous Pedicle Screw-Rod Fixation, Trans-sacral Fixation), Indication (Herniated Disc, Degenerative Disc Disease), End User (Hospitals, Orthopedic Clinics) – Global Outlook & Forecast 2023-2031
Smart Healthcare Market by Product (mHealth, RFID Kanban Systems), Application (Storage & Inventory Management, Monitoring) - Global Outlook and Forecast 2023-2031
Immunostimulants Market by Type (Vaccines, Interferons, Interleukins, Colony Stimulating Factor), Indications (Cancer, Immunodeficiency Disorder, and Organ Transplantations) – Global Outlook & Forecast 2023-2031
Veterinary Forceps Market by Type (Thumb Forceps, Hemostatic Forceps, Tissue Forceps, Other), En User (Veterinary Hospitals and Veterinary Clinics) – Global Outlook & Forecast 2021-2031
Hand Eczema Treatment Market by Drug Class (Topical Steroids, Calcineurin Inhibitors), Formulations (Creams & Lotions, Ointments), End User (Retail Pharmacies, Hospital Pharmacies) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020".
